Positive Momentum in Pharma and Biotech...Will the Trend Continue Through the First Half of Next Year?

The pharmaceutical and biotech sectors, which had been left out during the semiconductor-led market rally, have recently shown strong performance. The healthcare index is significantly outperforming the semiconductor index, with foreign investors also showing strong buying interest. Easing U.S. tariff risks and news of global new drug and technology transfers are boosting domestic investor sentiment.

Securities firms predict that this trend will continue through the first half of next year. The global trends in obesity and metabolic disease treatments, along with domestic companies’ technology exports and new drug approval achievements, are having a positive impact, leading to analysis that there is ample room for further gains. Experts advise, "It is effective to devise a bio investment strategy alongside semiconductors and high-dividend stocks to match the rotational market expected through the end of the year."

원본보기 아이콘

[Link to the No.1 industry leader HiStockLoan: https://www.hisl.co.kr/5113]

Meanwhile, interest in stock loans is increasing day by day. Investors who do not want to miss out on rare investment opportunities are turning to stock loans, which allow them to utilize more funds for stock purchases.

Additionally, one advantage of stock loans is that even if investors face the risk of forced liquidation due to a sharp drop in stock prices while using margin or credit, they can simply switch products without providing additional collateral or selling stocks, and wait for a rebound.

◆ HiStockLoan: Industry’s lowest annual interest rate in the 4% range, offering additional investment funds and even refinancing of margin and credit!

HiStockLoan has launched a securities-linked credit product with the industry’s lowest annual interest rate in the 4% range, allowing anyone to experience stock loans without burden. It can be used for both stock purchases and refinancing of margin/credit at securities firms, and can be leveraged up to four times including one’s own capital, regardless of credit rating.

In addition, for investors who have found it difficult to use stock loans due to DSR limits, products that can be used regardless of DSR are also available. Investors using the alternative trading system (NXT) can also take advantage of these offerings.

Investors who want to learn more about HiStockLoan’s various customized products can contact the customer service center (☎1566-5113) to receive convenient consultation from a professional advisor 24 hours a day, regardless of loan eligibility.

○ Launched industry’s lowest annual interest rate products in the 4% range

○ Offering products regardless of DSR

○ No.1 market share for 21 consecutive years, First Brand Award in Korea for 16 consecutive years

○ Real-time repayment of margin/credit at securities firms

○ Alternative trading system (NXT) transactions available

○ Reliable consultation quality guarantee system

* HiStockLoan Customer Service Center: 1566-5113

Go to: https://www.hisl.co.kr/5113

Samsung Electronics, SK Hynix, Doosan Enerbility, Naver, Hanwha Ocean

※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.